Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights

Ads

You May Also Like

FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)

Company Release no. 22/2018 To: NASDAQ Copenhagen A/S                                             Copenhagen, Denmark, 19 December 2018 ...